abstract |
The present invention relates to a compound represented by the formula (I), wherein (Ia), m, E, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are defined in the specification and claims. And the physiologically acceptable salts thereof. These compounds are antagonists of the CCR-2 receptor, CCR-5 receptor and / or CCR-3 receptor and are used as medicaments. |